 | • レポートコード：TPM-NV025 • 出版社/出版日：Transparency Market Research / 2019年10月22日 • レポート形態：英文、PDF、206ページ • 納品方法：Eメール • 産業分類：製薬 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、前立腺がん治療法の世界市場について調べ、前立腺がん治療法の世界市場規模、市場動向、市場シェア、市場環境、市場予測、療法別（ホルモン療法、化学療法、生物学的療法、および標的療法）分析、流通チャンネル別（病院薬局、小売薬局、オンライン販売、その他）分析、関連企業情報などをまとめました。 ・前立腺がん治療法の市場概要 ・前立腺がん治療法の市場動向 ・前立腺がん治療法の世界市場規模・予測 ・前立腺がん治療法市場：療法別（ホルモン療法、化学療法、生物学的療法、および標的療法） ・前立腺がん治療法市場：流通チャンネル別（病院薬局、小売薬局、オンライン販売、その他） ・地域別分析（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争環境・関連企業分析 |
Prostate Cancer Therapeutics Market – Scope of the Study
[206 Pages Report] Transparency Market Research (PMR) carried out a comprehensive analysis measuring the growth potential of the prostate cancer therapeutics market in its latest research report for the forecast period of 2019-2027. The business study encompasses some key insights for market players that can help them upkeep their position and consolidate their share in the market.
The research report intends to offer rare and distinguished information apropos of the growth of the prostate cancer therapeutics market, and brings to the fore the latent growth opportunities for market players. With the help of the insights found by this research, stakeholders operating in the prostate cancer therapeutics market will gain an incisive outlook pertaining to the growth trajectory, which can help them in making sustainable strategies for their business growth.
This exclusive business study consists of an incisive outlook regarding the evolution of the prostate cancer therapeutics market and changing dynamics during the course of the forecast period of 2019-2027. This exclusive business study provides information regarding the crucial drivers, threats, opportunities, and trends available in the prostate cancer therapeutics market, in order to equip stakeholders with the most recent developments and market shifts.
This detailed research report also covers a comprehensive SWOT analysis of the leading, prominent, and emerging market players functioning in the prostate cancer therapeutics market. This will aid stakeholders achieve an incisive outlook pertaining to the growth of the prostate cancer therapeutics market.
This exclusive guide analyzes and discusses Porter’s Five Forces to offer key growth strategies available in the prostate cancer therapeutics market during the forecast period. This comprehensive guide offers significant information about the competition present in the prostate cancer therapeutics market by determining key competitors. The exclusive report also includes key strategies, financials, and notable developments present in the prostate cancer therapeutics market during the forecast period of 2019-2027.
Prostate Cancer Therapeutics Market – Segmentation
In order to present an incisive view of the prostate cancer therapeutics market, analysts and researchers of the report have segregated the prostate cancer therapeutics market on the basis of therapy, distribution channel, and region. This comprehensive business study also analyzes the incremental opportunity present in the prostate cancer therapeutics market during the forecast period.
Prostate Cancer Therapeutics Market – Key Questions Answered
The report on the prostate cancer therapeutics market answers key concerns encircling the growth of the market.
What are the recent developments and market shifts observed in the prostate cancer therapeutics market?
What are the key winning imperatives for leading and prominent players functioning in the prostate cancer therapeutics market?
What are the significant trends stimulating the growth of the prostate cancer therapeutics market?
Which end-use industry will exert strong influence on the prostate cancer therapeutics market?
Prostate Cancer Therapeutics Market – Research Methodology
The research report conducted by Transparency Market Research (TMR) analysts consists of a systematic methodology, employed with a view to cull key insights pertaining to the growth of the prostate cancer therapeutics market during the forecast period of 2019-2027. Discussions with opinion leaders, market heads, vendors, distributors, industry experts, and key players were conducted in order to conduct primary research. In addition to this, our analysts also carried out a thorough secondary study of marketing collaterals, industry associations, company websites, and government statistics.
レポート目次1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology
3. Executive Summary
3.1. Global Prostate Cancer Therapeutics Market Snapshot, 2018
4. Market Overview
4.1. Therapy Overview
4.2. Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, 2017–2027
4.3. Global Prostate Cancer Therapeutics Market Outlook
4.4. Global Prostate Cancer Therapeutics Market : Key Industry Events
4.5. Global Prostate Cancer Therapeutics Market : Pipeline Analysis
4.6. Global Disease Prevalence & Incidence
4.7. Overall Prostate Cancer (2017–2027)
4.8. By Clinical Stages (2018)
5. Market Dynamics
5.1. Drivers
5.1.1. Increasing prevalence of prostate cancer
5.1.2. Launch of promising emerging therapies
5.1.3. Innovation in the development of new drugs and therapeutic biological products
5.1.4. High growth in hormone-refractory prostate cancer drug due to lesser side effects
5.2. Restrains
5.2.1. High cost of treatment
5.2.2. Reluctance toward adoption of premium treatments
5.3. Opportunities
5.3.1. Large undiagnosed patient population
5.3.2. Rise in funding from both public and private sector in the field of drug development
5.4. Key Trends
5.4.1. Increasing application of biotechnology in anticancer drugs development
5.4.2. New drugs entering the market with higher costs
5.4.3. Oral drugs account for a large share of the oncology drugs market
6. Global Prostate Cancer Therapeutics Market Analysis, by Therapy
6.1. Key Findings
6.2. Introduction
6.3. Global Prostate Cancer Therapeutics Market Value Share Analysis, by Therapy
6.4. Prostate Cancer Therapeutics Market Analysis, by Therapy
6.4.1. Hormone Therapy
6.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
6.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
6.4.1.3. Antiandrogens
6.4.2. Chemotherapy
6.4.2.1. Systemic Chemotherapy
6.4.2.2. Regional Chemotherapy
6.4.3. Biologic Therapy
6.4.4. Targeted Therapy
6.5. Global Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2019–2027
6.6. Key Trends
7. Global Prostate Cancer Therapeutics Market Analysis, by Distribution Channel
7.1. Key Findings
7.2. Introduction
7.3. Global Prostate Cancer Therapeutics Market Value Share Analysis, by Distribution Channel
7.4. Prostate Cancer Therapeutics Market Analysis, by Distribution Channel
7.4.1. Hospital Pharmacy
7.4.2. Retail Pharmacy
7.4.3. Online Sales
7.4.4. Others
7.5. Global Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019–2027
7.6. Key Trends
8. Global Prostate Cancer Therapeutics Market Analysis, by Region
8.1. Global Prostate Cancer Therapeutics Market Snapshot, by Country
8.2. Global Prostate Cancer Therapeutics Market Value Share Analysis, by Region
8.3. Prostate Cancer Therapeutics Market Forecast, by Region
8.4. Prostate Cancer Therapeutics Market Attractiveness Analysis, by Region, 2019–2027
9. North America Prostate Cancer Therapeutics Market Analysis
9.1. Market Outlook
9.2. North America Prostate Cancer Therapeutics Market Overview
9.3. North America Market Value Share Analysis, by Therapy
9.4. North America Market Forecast, by Therapy
9.4.1. Hormone Therapy
9.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
9.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
9.4.1.3. Antiandrogens
9.4.2. Chemotherapy
9.4.2.1. Systemic Chemotherapy
9.4.2.2. Regional Chemotherapy
9.4.3. Biologic Therapy
9.4.4. Targeted Therapy
9.5. North America Market Value Share Analysis, by Distribution Channel
9.6. North America Market Forecast, by Distribution Channel
9.6.1. Hospital Pharmacy
9.6.2. Retail Pharmacy
9.6.3. Online Sales
9.6.4. Others
9.7. Market Analysis, by Country
9.8. Market Value Share Analysis, by Country
9.9. Market Size (US$ Mn) Forecast, by Country, 2019–2027
9.9.1. U.S.
9.9.2. Canada
9.10. Market Attractiveness Analysis
9.10.1. By Therapy
9.10.2. By Distribution Channel
9.10.3. By Country
9.11. Market Trends
10. Europe Prostate Cancer Therapeutics Market Analysis
10.1. Market Outlook
10.2. Europe Prostate Cancer Therapeutics Market Overview
10.3. Europe Market Value Share Analysis, by Therapy
10.4. Europe Market Forecast, by Therapy
10.4.1. Hormone Therapy
10.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
10.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
10.4.1.3. Antiandrogens
10.4.2. Chemotherapy
10.4.2.1. Systemic Chemotherapy
10.4.2.2. Regional Chemotherapy
10.4.3. Biologic Therapy
10.4.4. Targeted Therapy
10.5. Europe Market Value Share Analysis, by Distribution Channel
10.6. Europe Market Forecast, by Distribution Channel
10.6.1. Hospital Pharmacy
10.6.2. Retail Pharmacy
10.6.3. Online Sales
10.6.4. Others
10.7. Market Analysis, by Country/Sub-region
10.8. Market Value Share Analysis, by Country/Sub-region
10.9. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2019–2027
10.9.1. U.K.
10.9.2. Germany
10.9.3. Italy
10.9.4. France
10.9.5. Spain
10.9.6. Russia
10.9.7. Rest of Europe
10.10. Market Attractiveness Analysis
10.10.1. By Therapy
10.10.2. By Distribution Channel
10.10.3. By Country/Sub-region
10.11. Market Trends
11. Asia Pacific Prostate Cancer Therapeutics Market Analysis
11.1. Market Outlook
11.2. Asia Pacific Prostate Cancer Therapeutics Market Overview
11.3. Asia Pacific Market Value Share Analysis, by Therapy
11.4. Asia Pacific Market Forecast, by Therapy
11.4.1. Hormone Therapy
11.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
11.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
11.4.1.3. Antiandrogens
11.4.2. Chemotherapy
11.4.2.1. Systemic Chemotherapy
11.4.2.2. Regional Chemotherapy
11.4.3. Biologic Therapy
11.4.4. Targeted Therapy
11.5. Asia Pacific Market Value Share Analysis, by Distribution Channel
11.6. Asia Pacific Market Forecast, by Distribution Channel
11.6.1. Hospital Pharmacy
11.6.2. Retail Pharmacy
11.6.3. Online Sales
11.6.4. Others
11.7. Market Analysis, by Country/Sub-region
11.8. Market Value Share Analysis, by Country/Sub-region
11.9. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2019–2027
11.9.1. China
11.9.2. Japan
11.9.3. India
11.9.4. Australia & New Zealand
11.9.5. Rest of Asia Pacific
11.10. Market Attractiveness Analysis
11.10.1. By Therapy
11.10.2. By Distribution Channel
11.10.3. By Country/Sub-region
11.11. Market Trends
12. Latin America Prostate Cancer Therapeutics Market Analysis
12.1. Market Outlook
12.2. Latin America Prostate Cancer Therapeutics Market Overview
12.3. Latin America Market Value Share Analysis, by Therapy
12.4. Latin America Market Forecast, by Therapy
12.4.1. Hormone Therapy
12.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
12.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
12.4.1.3. Antiandrogens
12.4.2. Chemotherapy
12.4.2.1. Systemic Chemotherapy
12.4.2.2. Regional Chemotherapy
12.4.3. Biologic Therapy
12.4.4. Targeted Therapy
12.5. Latin America Market Value Share Analysis, by Distribution Channel
12.6. Latin America Market Forecast, by Distribution Channel
12.6.1. Hospital Pharmacy
12.6.2. Retail Pharmacy
12.6.3. Online Sales
12.6.4. Others
12.7. Market Analysis, by Country/Sub-region
12.8. Market Value Share Analysis, by Country/Sub-region
12.9. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2019–2027
12.9.1. Brazil
12.9.2. Mexico
12.9.3. Rest of Latin America
12.10. Market Attractiveness Analysis
12.10.1. By Therapy
12.10.2. By Distribution Channel
12.10.3. By Country/Sub-region
12.11. Market Trends
13. Middle East & Africa Prostate Cancer Therapeutics Market Analysis
13.1. Market Outlook
13.2. Middle East & Africa Prostate Cancer Therapeutics Market Overview
13.3. Middle East & Africa Market Value Share Analysis, by Therapy
13.4. Middle East & Africa Market Forecast, by Therapy
13.4.1. Hormone Therapy
13.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
13.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
13.4.1.3. Antiandrogens
13.4.2. Chemotherapy
13.4.2.1. Systemic Chemotherapy
13.4.2.2. Regional Chemotherapy
13.4.3. Biologic Therapy
13.4.4. Targeted Therapy
13.5. Middle East & Africa Market Value Share Analysis, by Distribution Channel
13.6. Middle East & Africa Market Forecast, by Distribution Channel
13.6.1. Hospital Pharmacy
13.6.2. Retail Pharmacy
13.6.3. Online Sales
13.6.4. Others
13.7. Market Analysis, by Country/Sub-region
13.8. Market Value Share Analysis, by Country/Sub-region
13.9. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2019–2027
13.9.1. Saudi Arabia
13.9.2. South Africa
13.9.3. UAE
13.9.4. Rest of Middle East & Africa
13.10. Market Attractiveness Analysis
13.10.1. By Therapy
13.10.2. By Distribution Channel
13.10.3. By Country
13.11. Market Trends
14. Company Profiles
14.1. Prostate Cancer Therapeutics Market Share Analysis, by Company, 2018 (Estimated)
14.2. Competition Matrix
14.3. Company Profiles
14.3.1. Amgen, Inc.
14.3.2. Johnson & Johnson (Janssen Biotech, Inc.)
14.3.3. Pfizer, Inc.
14.3.4. AstraZeneca
14.3.5. AbbVie, Inc.
14.3.6. Bayer AG
14.3.7. Ipsen Group
14.3.8. Sanofi
14.3.9. Endo Pharmaceuticals, Inc.
14.3.10. Dendreon Corporation (Sanpower Group Co. Ltd.)
Table 1: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017–2027
Table 2: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017–2027
Table 3: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2017–2027
Table 4: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 5: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 6: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017–2027
Table 7: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017–2027
Table 8: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2017–2027
Table 9: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 10: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 11: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017–2027
Table 12: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017–2027
Table 13: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2017–2027
Table 14: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 15: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017–2027
Table 17: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017–2027
Table 18: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2017–2027
Table 19: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 20: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017–2027
Table 22: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017–2027
Table 23: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2017–2027
Table 24: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 25: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 26: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017–2027
Table 27: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017–2027
Table 28: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy (Therapy), 2017–2027
Table 29: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 30: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027